A Study On The Financing Strategy Of BeiGene Shenzhou From The Life Cycle Theory

As one of the most promising industries at present,the biopharmaceutical industry has played a vital role in promoting our country’s economic growth and improving medical care.With the introduction of relevant policies by the National Development and Reform Commission and the State Council,our country will focus on supporting the in-depth development of the biopharmaceutical industry.Although our country is a major producer and consumer of biopharmaceutical products,due to the high investment,long cycle and high risk characteristics of the biopharmaceutical industry,biopharmaceutical companies generally face a shortage of funds,and our country lacks independent research and development of biopharmaceutical companies.Therefore,how to formulate an appropriate financing strategy has become the primary issue for the survival and development of biopharmaceutical companies.This thesis selects BeiGene as a research case,which is a biopharmaceutical company that has been listed for IPO financing in the US stock market,Hong Kong stock market,and A-share market.Based on the perspective of the life cycle theory,the development process of BeiGene is analyzed in detail,and its financing strategies at different stages of the life cycle are studied.Qualitative and quantitative methods are used to evaluate its financing effectiveness.This thesis summarizes the suitable financing strategies of biopharmaceutical companies under different life cycles,aiming to provide reference for financing decisions of other biopharmaceutical companies.Through the study of BeiGene’s financing strategy,this thesis believes that BeiGene’s financing strategy has the following successes:Firstly,BeiGene’s financing strategy matches the characteristics of the enterprise life cycle;secondly,BeiGene’s financing strategy is formulated based on the development strategy of the enterprise and is continuously adjusted according to the development needs.The research contribution of this thesis is to propose financing strategies for biopharmaceutical companies at different stages of their life cycle,and provide the following inspirations for other biopharmaceutical companies:Firstly,it is necessary to plan the financing process rationally;secondly,it is necessary to strengthen international cooperation and pay attention to overseas market layout;thirdly,technological innovation is the fundamental driving force to expand financing channels;fourthly,in addition to focusing on research and development investment,the construction of the marketing network should also be strengthened.